Samuel M Silvestre (Samuel Silvestre)

Scopus Author ID ResearcherID Ciência ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 33

Top Venues

Molecules (Basel, Switzerland)

International journal of molecular sciences

Pharmaceutics

Biomedicines

Faculty of Health Sciences, University of Beira Interior

Faculty of Pharmacy, University of Coimbra (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Faculty of Health Sciences, University of Beira Interior Jul 22 2009

Portugal

Assistant Professor :: Department of Medical Sciences

Education History

Faculty of Pharmacy, University of Coimbra Feb 01 2003 - May 17 2007

Portugal

PHD

Publications

Ângela Gonçalves, Mariana Matias, Jorge A R Salvador, Samuel M Silvestre
Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use? International journal of molecular sciences 25 (3) (2024)
Ângela Gonçalves, Mariana Matias, Jorge A R Salvador, Samuel M Silvestre
Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use? International journal of molecular sciences 25 (3) (2024)
Ângela Gonçalves, Mariana Matias, Jorge A R Salvador, Samuel M Silvestre
Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use? International journal of molecular sciences 25 (3) (2024)
Ângela Gonçalves, Mariana Matias, Jorge A R Salvador, Samuel M Silvestre
Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use? International journal of molecular sciences 25 (3) (2024)
Ângela Gonçalves, Mariana Matias, Jorge A R Salvador, Samuel M Silvestre
Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use? International journal of molecular sciences 25 (3) (2024)
Patrícia C Pires, Mariana Fernandes, Francisca Nina, Francisco Gama, Maria F Gomes, Lina E Rodrigues, Sara Meirinho, Samuel M Silvestre, Gilberto Alves, Adriana O Santos
Innovative Aqueous Nanoemulsion Prepared by Phase Inversion Emulsification with Exceptional Homogeneity. Pharmaceutics 15 (7) (2023)
Mariana Matias, Adriana O Santos, Samuel M Silvestre, Gilberto Alves
Fighting Epilepsy with Nanomedicines-Is This the Right Weapon? Pharmaceutics 15 (2) (2023)
Madalena Santos, Raquel Santos, Pedro Soeiro, Samuel M Silvestre, Susana M P Ferreira
Resveratrol as an Inhibitor of the NorA Efflux Pump and Resistance Modulator in Staphylococcus aureus . Antibiotics (Basel, Switzerland) 12 (7) (2023)
Romina A Guedes, Jorge H Grilo, Andreia Neves Carvalho, Pedro M P Fernandes, Ana S Ressurreição, Vanessa Brito, Adriana O Santos, Samuel M Silvestre, Eleonora Gallerani, Maria João Gama, Riccardo Gavioli, Jorge A R Salvador, Rita C Guedes
New Scaffolds of Proteasome Inhibitors: Boosting Anticancer Potential by Exploiting the Synergy of In Silico and In Vitro Methodologies. Pharmaceuticals (Basel, Switzerland) 16 (8) (2023)
Vanessa Brito, Mariana Marques, Marta Esteves, Catarina Almeida, Gilberto Alves, Paulo Almeida, Liliana Bernardino, Samuel M Silvestre
Synthesis, In Vitro Biological Evaluation of Antiproliferative and Neuroprotective Effects and In Silico Studies of Novel 16 E -Arylidene-5α,6α-epoxyepiandrosterone Derivatives. Biomedicines 11 (3) (2023)
Vanessa Brito, Mariana Marques, Marta Esteves, Catarina Almeida, Gilberto Alves, Paulo Almeida, Liliana Bernardino, Samuel M Silvestre
Synthesis, In Vitro Biological Evaluation of Antiproliferative and Neuroprotective Effects and In Silico Studies of Novel 16 E -Arylidene-5α,6α-epoxyepiandrosterone Derivatives. Biomedicines 11 (3) (2023)
Mariana Matias, Adriana O Santos, Samuel M Silvestre, Gilberto Alves
Fighting Epilepsy with Nanomedicines-Is This the Right Weapon? Pharmaceutics 15 (2) (2023)
Daniela Rodrigues, Samuel M Silvestre, Cristina Sofia de Jesus Monteiro, Ana Paula Coelho Duarte
Medication and the Risk of Falls: An Analysis of Adverse Drug Reactions Reported to the Portuguese Pharmacovigilance System. Journal of clinical medicine 12 (23) (2023)
Mariana Matias, Adriana O Santos, Samuel M Silvestre, Gilberto Alves
Fighting Epilepsy with Nanomedicines-Is This the Right Weapon? Pharmaceutics 15 (2) (2023)
Cristina Sofia de Jesus Monteiro, Samuel M Silvestre, Ana Paula Coelho Duarte, Gilberto Alves
Safety of Non-Steroidal Anti-Inflammatory Drugs in the Elderly: An Analysis of Published Literature and Reports Sent to the Portuguese Pharmacovigilance System. International journal of environmental research and public health 19 (6) (2022)
Radhia Aitfella Lahlou, Nsevolo Samba, Pedro F Soeiro, Gilberto Alves, Ana Carolina Gonçalves, Luís Manuel Lopes Rodrigues da Silva, Samuel M Silvestre, Jesus Miguel López Rodilla, Maria Isabel Ismael
Thymus hirtus Willd. ssp. algeriensis Boiss. and Reut: A Comprehensive Review on Phytochemistry, Bioactivities, and Health-Enhancing Effects. Foods (Basel, Switzerland) 11 (20) (2022)
Bruno M F Gonçalves, Vanessa I S Mendes, Samuel M Silvestre, Jorge A R Salvador
Design, synthesis, and biological evaluation of new arjunolic acid derivatives as anticancer agents. RSC medicinal chemistry 14 (2) (2022)
Diana Gomes, Shivani Yaduvanshi, Samuel M Silvestre, Ana Paula Coelho Duarte, Adriana O Santos, Christiane P Soares, Veerendra Kumar, Luís António Paulino Passarinha, Ângela Sousa
Taxifolin and Lucidin as Potential E6 Protein Inhibitors: p53 Function Re-Establishment and Apoptosis Induction in Cervical Cancer Cells. Cancers 14 (12) (2022)
João L Serrano, Ana Maia, Adriana O Santos, Eurico Lima, Lucinda V Reis, Maria J Nunes, Renato E F Boto, Samuel M Silvestre, Paulo Almeida
An Insight into Symmetrical Cyanine Dyes as Promising Selective Antiproliferative Agents in Caco-2 Colorectal Cancer Cells. Molecules (Basel, Switzerland) 27 (18) (2022)
Vanessa Brito, Adriana Oliveira Santos, Gilberto Alves, Paulo Almeida, Samuel M Silvestre
Novel 4-Azapregnene Derivatives as Potential Anticancer Agents: Synthesis, Antiproliferative Activity and Molecular Docking Studies. Molecules (Basel, Switzerland) 27 (18) (2022)
Bruno M F Gonçalves, Vanessa I S Mendes, Samuel M Silvestre, Jorge A R Salvador
Design, synthesis, and biological evaluation of new arjunolic acid derivatives as anticancer agents. RSC medicinal chemistry 14 (2) (2022)
Marina C Posso, Fernanda C Domingues, Susana M P Ferreira, Samuel M Silvestre
Development of Phenothiazine Hybrids with Potential Medicinal Interest: A Review. Molecules (Basel, Switzerland) 27 (1) (2022)
Miguel Vaz, Vítor Silva, Cristina Sofia de Jesus Monteiro, Samuel M Silvestre
Role of Aducanumab in the Treatment of Alzheimer's Disease: Challenges and Opportunities. Clinical interventions in aging 17 (2022)
João L Serrano, Diana Lopes, Melani J A Reis, Renato E F Boto, Samuel M Silvestre, Paulo Almeida
Bis-thiobarbiturates as Promising Xanthine Oxidase Inhibitors: Synthesis and Biological Evaluation. Biomedicines 9 (10) (2021)
Pedro Cruz-Vicente, Luís António Paulino Passarinha, Samuel M Silvestre, Eugenia Gallardo
Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches. Molecules (Basel, Switzerland) 26 (8) (2021)
Catarina Canário, Mariana Matias, Vanessa Brito, Adriana O Santos, Amílcar Falcão, Samuel M Silvestre, Gilberto Alves
New Estrone Oxime Derivatives: Synthesis, Cytotoxic Evaluation and Docking Studies. Molecules (Basel, Switzerland) 26 (9) (2021)
Vanessa Brito, Gilberto Alves, Paulo Almeida, Samuel M Silvestre
Highlights on Steroidal Arylidene Derivatives as a Source of Pharmacologically Active Compounds: A Review. Molecules (Basel, Switzerland) 26 (7) (2021)
Pedro Cruz-Vicente, Ana M Gonçalves, Octávio Ferreira, João A Queiroz, Samuel M Silvestre, Luís António Paulino Passarinha, Eugenia Gallardo
Discovery of Small Molecules as Membrane-Bound Catechol- O -methyltransferase Inhibitors with Interest in Parkinson's Disease: Pharmacophore Modeling, Molecular Docking and In Vitro Experimental Validation Studies. Pharmaceuticals (Basel, Switzerland) 15 (1) (2021)
Diana Gomes, Samuel M Silvestre, Ana Paula Coelho Duarte, Aldo Venuti, Christiane P Soares, Luís António Paulino Passarinha, Ângela Sousa
In Silico Approaches: A Way to Unveil Novel Therapeutic Drugs for Cervical Cancer Management. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)
João L Serrano, Joana Figueiredo, Paulo Almeida, Samuel M Silvestre
From Xanthine Oxidase Inhibition to In Vivo Hypouricemic Effect: An Integrated Overview of In Vitro and In Vivo Studies with Focus on Natural Molecules and Analogues. Evidence-based complementary and alternative medicine : eCAM 2020 (2020)
Samuel M Silvestre, Paulo J S Almeida, Reda El-Shishtawy
Natural Products as a Source for New Leads in Gout Treatment. Evidence-based complementary and alternative medicine : eCAM 2020 (2020)
João L Serrano, Pedro F Soeiro, Melani A Reis, Renato E F Boto, Samuel M Silvestre, Paulo Almeida
Synthesis and process optimization of symmetric and unsymmetric barbiturates C5-coupled with 2,1-benzisoxazoles. Molecular diversity 24 (1) (2019)
Mafalda Jesus, Ana P J Martins, Eugenia Gallardo, Samuel M Silvestre
Diosgenin: Recent Highlights on Pharmacology and Analytical Methodology. Journal of analytical methods in chemistry 2016 (2016)

Samuel M Silvestre.css-eqlu8i{font-size:small;padding-left:4px;} (Samuel Silvestre)

Publication Activity (10 Years)

Top Topics

Top Venues

Samuel M Silvestre (Samuel Silvestre)